TestBankForClayton’sBasicPharmacologyforNurses19th Editi
cx
on
ByMichelleJ.Willihnganz,SamuelL.Gurevitz,BruceClayton Cc x
omplete
,Chaptercx01:cxDrugcxDefinitions,cxStandards,cxandcxInformationcxSourcescxWillihnganz:c
xClayton’scxBasiccxPharmacologycxforcxNurses,cx19thcxEdition
MULTIPLEcxCHOICE
1. WhichcxnamecxidentifiescxavdrugcxlistedcxbythecxUScxFoodcx
andcxDrugcxAdministrationcx(FDA)?
a. Brand
b. Nonproprietary
c. Official
d. Trademark
ANS:cxC
Thecxofficialcxnamecxiscxthec x namecxundercxwhichvacxdrugcxiscxliste
dcxbycxthecxFDA.cxThecxbrandcxname,cxorcxtrademark,cxiscxthecxna
mevgivencxtcxocxacxdrugcxbycxitscxmanufacturer.cxThecxnonproprie
tary,cxorcxgeneric,cxnamecxiscxprovidedcxbycxthecxUnitedcxStatescx
AdoptedcxNamescxCouncxcil.
DIF: CognitivecxLevel:cxKnowledge REF:c x p.cx9
OBJ:cx1NAT:cxNCLEXcxClientcxNeedscxCategory:cxSafe,cxEffectivecxCarecxEnviro
nmentcxTOP:c x NursingcxProcesscxStep:cxAssessment
CON:
PatientcxEducation
2. Whichcxsourcecxcontainscxinformationcxspecificcxtocxnutritionalcxsupplements?
a. USPDictionarycxofcxUSANcx&InternationalcxDrugcxNames
b. NaturalcxMedicinescxComprehensivecxDatabase
c. UnitedcxStatescxPharmacopoeia/NationalcxFormulary(USPNF)
d. DrugcxInteractioncxFacts
ANS:cxC
UnitedcxStatescxPharmacopoeia/NationalcxFormularycxcontainscxinformationcxspecificcxtocxnutrition
alc x scxupplements.cxUSPcxDictionaryvofcxUSANcx&cxInternationalcxDrugcxNamescxiscxacxcompilationcx
ofcxdrugcxnacxmes,cxpronunciationcxguide,cxandcxpossiblecxfuturecxFDAcxapprovedcxdrugs;cxitcxdoescxno
tcxincludecxnutritiocxnalcxsupplements.cxNaturalcxMedicinescxComprehensivecxDatabasecxcontains
evidence-
basedcxinformationcxoncxherbalcxmedicinescxandcxherbalcxcombinationcxproducts;cxitcxdoescxnotcxinclu
decxinfcxormationcxspecificcxtocxnutritionalcxsupplements.cxDrugcxInteractioncxFactscxcontainscxcomp
rehensivecxicxnformationcxoncxdrugcxinteractioncxfacts;cxitcxdoescxnotcxincludevnutritionalcxsupplem
ents.
DIF: CognitivecxLevel:cxKnowledge REF:c x p.cx4
OBJ:cx3cxNAT:c x NCLEXcxClientcxNeedscxCategory:cxPhysiologicalcxInteg
rity
TOP:c x NursingcxProcesscxStep:cxAssessment CON:cxNutritioncx|cxPatientcxEducation
3. Whichcxdrugcxreferencecxcontainscxdrugcxmonographscxthatcxdescribecxallcxdrugscxincxacxtherapeuticcxclass?
a. DrugcxFactscxandcxComparisons
,TestcxBankcxForvClayton’scxBasiccxPharmacologyvforvNursescx19thcxEdi 3
tion
b. DrugcxInteractioncxFacts
c. HandbookcxoncxInjectablecxDrugs
d. Martindale—ThecxCompletecxDrugcxReference
ANS:cxA
DrugcxFactscxandcxComparisonscxcontainscxdrugcxmonographscxthatcxdescribevallcxdrugscxincxacx
thcxerapeuticcxclass.cxMonographscxarecxformattedcxascxtablescxtocxallowcxcomparisoncxofcxsimila
rcxprocxducts,cxbrandcxnames,cxmanufacturers,cxcostcxindices,cxandcxavailablecxdosagecxformscxO
nlinevvecxrsionviscxavailable.
DIF: CognitivecxLevel:cxKnowledge REF:c x p.cx4vTablecx1.2
OBJ:c x c x 3 NAT:c x NCLEXcxClientcxNeedscxCategory:cxPhysiologicalcxIntegrity
TOP:c x NursingcxProcesscxStep:cxAssessment CON:cxSafetycx|cxPatientcxEducationcx|cxClinicalcxJudgment
4. Whichcxdrugcxreferencecxcontainscxmonographscxaboutvvirtuallycxeverysingle-
entitydrugcxavailablecxincxthevUnitedcxStatescxandcxdescribescxtherapeuticcxusescxofcxdrugs,cxincluding
cxapcxprovedcxandcxunapprovedcxuses?
a. Martindale:cxThecxCompletecxDrugcxReference
b. AHFScxDrugcxInformation
c. DrugcxReference
d. DrugcxFactscxandvComparisons
ANS:cxB
AHFScxDrugcxInformationcxcontainscxmonographscxaboutcxvirtuallycxeverycxsingle-
entitycxdrugcxavailablecxincxthecxUnitedcxStatescxandcxdescribescxtherapeuticcxusescxofcxdrugs,cxincludingcx
apprcxovedcxandcxunapprovedcxuses.
DIF: CognitivecxLevel:cxKnowledge REF:c x p.cx4vTablecx1.2
OBJ:c x c x 3 NAT:c x NCLEXcxClientcxNeedscxCategory:cxPhysiologicalcxIntegrity
TOP:c x NursingcxProcesscxStep:cxPlanning CON:cxSafetycx|cxPatientcxEducationcx|cxClinicalcxJudgment
5. Whichcxonlinecxdrugcxreferencecxmakescxavailablecxtocxhealthcarecxproviderscxandcxthecxpubliccxacx
standcxard,cxcomprehensive,cxup-to-
datecxlookcxupcxandcxdownloadablecxresourcecxaboutcxmedicines?
a. AmericancxDrugcxIndex
b. AmericancxHospitalcxFormulary
c. DailyMed
d. DrugcxReference
ANS:cxC
DailyMedcxmakescxavailablecxtocxhealthcarecxproviderscxandcxthecxpubliccxacxstandard,cxcomprehen
sive,cxup-to-
datecxlookcxupcxandcxdownloadablecxresourcecxaboutcxmedicines.cxThecxAmericancxDrugcxIndexcxiscxnotcx
appcxropriatecxforcxpatientcxuse.cxThecxAmericancxHospitalcxFormularycxiscxnotcxappropriatecxforcxpa
tientcxuse.cxThecxdrugcxreferencecxiscxnotcxappropriatecxforcxpatientcxuse.
DIF: CognitivecxLevel:cxKnowledge REF:c x p.cx3cx|cxp.cx4
OBJ:cx3cxNAT:c x NCLEXcxClientcxNeedscxCategory:cxPhysiologicalcxInteg
rity
TOP:cxNursingcxProcesscxStep:cxImplementation
CON:cxSafetycx|cxPatientcxEducationcx|cxClinicalcxJudgment
6. WhichcxlegislationcxauthorizescxthecxFDAcxtocxdeterminecxthecxsafetyofcxacxdrugcxbeforecxitscxmarketing?
a. FederalcxFood,cxDrug,cxandcxCosmeticcxActcx(1938)
b. DurhamcxHumphreycxAmendmentcx(1952)
, TestcxBankcxForvClayton’scxBasiccxPharmacologyvforvNursescx19thcxEdi 4
tion
c. ControlledcxSubstancescxActcx(1970)
d. KefauvercxHarriscxDrugcxAmendmentcx(1962)
ANS:cxA
ThecxFederalcxFood,cxDrug,cxandcxCosmeticcxActvofcx1938cxauthorizedcxthecxFDAcxtocxdeterminevth
ecxsafetcxycxofcxallcxdrugsvbeforecxmarketing.cxLatercxamendmentscxandcxactscxhelpedcxtightencxFDAcxc
ontrolcxandcxencxsurevdrugcxsafety.cxThecxDurhamcxHumphreycxAmendmentcxdefinescxthecxkindscxofcx
drugscxthatcxcannotcxbecxusedcxsafelycxwithoutcxmedicalcxsupervisioncxandcxrestrictscxtheircxsalecxtocx
prescriptioncxbycxacxlicensedcxprcxactitioner.cxThecxControlledcxSubstancescxActcxaddressescxonlycxcon
trolledcxsubstancescxandcxtheircxcategocxrization.cxThecxKefauvercxHarriscxDrugcxAmendmentcxensur
escxdrugvefficacycxandcxgreatercxdrugcxsafety.cxDrugcxmanufacturerscxarecxrequiredcxtocxprovevtocxthev
FDAcxthecxeffectivenesscxofcxtheircxproductscxbeforecxmarketingcxthem.
DIF: CognitivecxLevel:cxKnowledge
REF:c x p.cx5cxTablecxl.3cxOBJ:c x 5
NAT:cxNCLEXcxClientcxNeedscxCategory:cxPhysiologicalcxIntegrit
ycxTOP:c x NursingcxProcesscxStep:cxAssessment
CON:c x Safetycx|cxPatientcxEducationcx|cxEvidencecx|cxHealthcxCarecxLaw
7. Whichcxclassificationcxdoescxmeperidinecx(Demerol)cxfallcxunder?
a. I
b. II
c. III
d. IV
ANS:cxB
Meperidinecx(Demerol)cxiscxacxSchedulecxIIcxdrug;cxitcxhascxacxhighcxpotentialcxforcxabusecxandcxmaycxle
adcxtocxsecxverecxpsychologicalcxandcxphysicalcxdependence.cxSchedulecxIcxdrugscxhavecxhighcxpotential
cxforcxabusecxandcxnocxrecognizedcxmedicalcxuse.cxSchedulecxIIIcxdrugscxhavevsomecxpotentialcxforcxa
buse.cxUsecxmaycxleadcxtocxlowcxtocxmoderatecxphysicalcxdependencecxorcxhighcxpsychologicalcxdepen
dence.cxSchedulevIVcxdrugscxhacxvecxlowcxpotentialcxforcxabuse.cxUsecxmaycxleadcxtocxlimitedcxphysi
calcxorcxpsychologicalcxdependence.
DIF:c x c x CognitivecxLevel:cxKnowledge REF:c x p.cx10
OBJ:cx2cxNAT:c x NCLEXcxClientcxNeedscxCategory:cxSafe,cxEffective
cxCarcxecxEnvironment
TOP:c x NursingcxProcesscxStep:cxAssessmentc x c x CON:c x PatientvEducationcx|cxAddictioncx|cxPain
8. WhichcxactioncxwouldcxthecxFDAcxtakecxtovexpeditecxdrugvdevelopmentcxandcxapprovalcxforcxancxoutbr
eakcxocxfcxsmallpox?
a. Listcxsmallpoxcxascxacxhealthcxorphancxdisease.
b. Omitcxthecxpreclinicalcxresearchcxphase.
c. Extendvthecxclinicalcxresearchcxphase.
d. Fastcxtrackcxthecxinvestigationalcxdrug.
ANS:cxD
OncecxthecxInvestigationalcxNewcxDrugcxApplicationcxhascxbeencxapproved,cxthecxdrugcxcancxreceive
cxhighcxestcxprioritycxwithincxthevagency,cxwhichcxiscxcalledcxfastcxtracking.cxAcxsmallpoxcxoutbreakc
xwouldcxbecocxmecxacxprioritycxconcerncxincxthecxworld.cxOrphancxdiseasescxarecxnotcxresearchedcxincxac
xprioritycxmanner.cxPrcxeclinicalcxresearchcxiscxnotcxomitted.cxExtendingvanycxphasecxofcxthecxresearchc
xwouldcxmeancxacxlongercxtimcxecxtocxdevelopcxacxvaccine.cxThecxFDAcxmustcxensurecxthatcxallcxphasescxofcx
thecxpreclinicalcxandcxclinicalcxreseacxrchcxphasevhavecxbeencxcompletedcxincxacxsafecxmanner.
DIF: CognitivecxLevel:cxKnowledge REF:c x p.cx7 OBJ:cx5
cx
on
ByMichelleJ.Willihnganz,SamuelL.Gurevitz,BruceClayton Cc x
omplete
,Chaptercx01:cxDrugcxDefinitions,cxStandards,cxandcxInformationcxSourcescxWillihnganz:c
xClayton’scxBasiccxPharmacologycxforcxNurses,cx19thcxEdition
MULTIPLEcxCHOICE
1. WhichcxnamecxidentifiescxavdrugcxlistedcxbythecxUScxFoodcx
andcxDrugcxAdministrationcx(FDA)?
a. Brand
b. Nonproprietary
c. Official
d. Trademark
ANS:cxC
Thecxofficialcxnamecxiscxthec x namecxundercxwhichvacxdrugcxiscxliste
dcxbycxthecxFDA.cxThecxbrandcxname,cxorcxtrademark,cxiscxthecxna
mevgivencxtcxocxacxdrugcxbycxitscxmanufacturer.cxThecxnonproprie
tary,cxorcxgeneric,cxnamecxiscxprovidedcxbycxthecxUnitedcxStatescx
AdoptedcxNamescxCouncxcil.
DIF: CognitivecxLevel:cxKnowledge REF:c x p.cx9
OBJ:cx1NAT:cxNCLEXcxClientcxNeedscxCategory:cxSafe,cxEffectivecxCarecxEnviro
nmentcxTOP:c x NursingcxProcesscxStep:cxAssessment
CON:
PatientcxEducation
2. Whichcxsourcecxcontainscxinformationcxspecificcxtocxnutritionalcxsupplements?
a. USPDictionarycxofcxUSANcx&InternationalcxDrugcxNames
b. NaturalcxMedicinescxComprehensivecxDatabase
c. UnitedcxStatescxPharmacopoeia/NationalcxFormulary(USPNF)
d. DrugcxInteractioncxFacts
ANS:cxC
UnitedcxStatescxPharmacopoeia/NationalcxFormularycxcontainscxinformationcxspecificcxtocxnutrition
alc x scxupplements.cxUSPcxDictionaryvofcxUSANcx&cxInternationalcxDrugcxNamescxiscxacxcompilationcx
ofcxdrugcxnacxmes,cxpronunciationcxguide,cxandcxpossiblecxfuturecxFDAcxapprovedcxdrugs;cxitcxdoescxno
tcxincludecxnutritiocxnalcxsupplements.cxNaturalcxMedicinescxComprehensivecxDatabasecxcontains
evidence-
basedcxinformationcxoncxherbalcxmedicinescxandcxherbalcxcombinationcxproducts;cxitcxdoescxnotcxinclu
decxinfcxormationcxspecificcxtocxnutritionalcxsupplements.cxDrugcxInteractioncxFactscxcontainscxcomp
rehensivecxicxnformationcxoncxdrugcxinteractioncxfacts;cxitcxdoescxnotcxincludevnutritionalcxsupplem
ents.
DIF: CognitivecxLevel:cxKnowledge REF:c x p.cx4
OBJ:cx3cxNAT:c x NCLEXcxClientcxNeedscxCategory:cxPhysiologicalcxInteg
rity
TOP:c x NursingcxProcesscxStep:cxAssessment CON:cxNutritioncx|cxPatientcxEducation
3. Whichcxdrugcxreferencecxcontainscxdrugcxmonographscxthatcxdescribecxallcxdrugscxincxacxtherapeuticcxclass?
a. DrugcxFactscxandcxComparisons
,TestcxBankcxForvClayton’scxBasiccxPharmacologyvforvNursescx19thcxEdi 3
tion
b. DrugcxInteractioncxFacts
c. HandbookcxoncxInjectablecxDrugs
d. Martindale—ThecxCompletecxDrugcxReference
ANS:cxA
DrugcxFactscxandcxComparisonscxcontainscxdrugcxmonographscxthatcxdescribevallcxdrugscxincxacx
thcxerapeuticcxclass.cxMonographscxarecxformattedcxascxtablescxtocxallowcxcomparisoncxofcxsimila
rcxprocxducts,cxbrandcxnames,cxmanufacturers,cxcostcxindices,cxandcxavailablecxdosagecxformscxO
nlinevvecxrsionviscxavailable.
DIF: CognitivecxLevel:cxKnowledge REF:c x p.cx4vTablecx1.2
OBJ:c x c x 3 NAT:c x NCLEXcxClientcxNeedscxCategory:cxPhysiologicalcxIntegrity
TOP:c x NursingcxProcesscxStep:cxAssessment CON:cxSafetycx|cxPatientcxEducationcx|cxClinicalcxJudgment
4. Whichcxdrugcxreferencecxcontainscxmonographscxaboutvvirtuallycxeverysingle-
entitydrugcxavailablecxincxthevUnitedcxStatescxandcxdescribescxtherapeuticcxusescxofcxdrugs,cxincluding
cxapcxprovedcxandcxunapprovedcxuses?
a. Martindale:cxThecxCompletecxDrugcxReference
b. AHFScxDrugcxInformation
c. DrugcxReference
d. DrugcxFactscxandvComparisons
ANS:cxB
AHFScxDrugcxInformationcxcontainscxmonographscxaboutcxvirtuallycxeverycxsingle-
entitycxdrugcxavailablecxincxthecxUnitedcxStatescxandcxdescribescxtherapeuticcxusescxofcxdrugs,cxincludingcx
apprcxovedcxandcxunapprovedcxuses.
DIF: CognitivecxLevel:cxKnowledge REF:c x p.cx4vTablecx1.2
OBJ:c x c x 3 NAT:c x NCLEXcxClientcxNeedscxCategory:cxPhysiologicalcxIntegrity
TOP:c x NursingcxProcesscxStep:cxPlanning CON:cxSafetycx|cxPatientcxEducationcx|cxClinicalcxJudgment
5. Whichcxonlinecxdrugcxreferencecxmakescxavailablecxtocxhealthcarecxproviderscxandcxthecxpubliccxacx
standcxard,cxcomprehensive,cxup-to-
datecxlookcxupcxandcxdownloadablecxresourcecxaboutcxmedicines?
a. AmericancxDrugcxIndex
b. AmericancxHospitalcxFormulary
c. DailyMed
d. DrugcxReference
ANS:cxC
DailyMedcxmakescxavailablecxtocxhealthcarecxproviderscxandcxthecxpubliccxacxstandard,cxcomprehen
sive,cxup-to-
datecxlookcxupcxandcxdownloadablecxresourcecxaboutcxmedicines.cxThecxAmericancxDrugcxIndexcxiscxnotcx
appcxropriatecxforcxpatientcxuse.cxThecxAmericancxHospitalcxFormularycxiscxnotcxappropriatecxforcxpa
tientcxuse.cxThecxdrugcxreferencecxiscxnotcxappropriatecxforcxpatientcxuse.
DIF: CognitivecxLevel:cxKnowledge REF:c x p.cx3cx|cxp.cx4
OBJ:cx3cxNAT:c x NCLEXcxClientcxNeedscxCategory:cxPhysiologicalcxInteg
rity
TOP:cxNursingcxProcesscxStep:cxImplementation
CON:cxSafetycx|cxPatientcxEducationcx|cxClinicalcxJudgment
6. WhichcxlegislationcxauthorizescxthecxFDAcxtocxdeterminecxthecxsafetyofcxacxdrugcxbeforecxitscxmarketing?
a. FederalcxFood,cxDrug,cxandcxCosmeticcxActcx(1938)
b. DurhamcxHumphreycxAmendmentcx(1952)
, TestcxBankcxForvClayton’scxBasiccxPharmacologyvforvNursescx19thcxEdi 4
tion
c. ControlledcxSubstancescxActcx(1970)
d. KefauvercxHarriscxDrugcxAmendmentcx(1962)
ANS:cxA
ThecxFederalcxFood,cxDrug,cxandcxCosmeticcxActvofcx1938cxauthorizedcxthecxFDAcxtocxdeterminevth
ecxsafetcxycxofcxallcxdrugsvbeforecxmarketing.cxLatercxamendmentscxandcxactscxhelpedcxtightencxFDAcxc
ontrolcxandcxencxsurevdrugcxsafety.cxThecxDurhamcxHumphreycxAmendmentcxdefinescxthecxkindscxofcx
drugscxthatcxcannotcxbecxusedcxsafelycxwithoutcxmedicalcxsupervisioncxandcxrestrictscxtheircxsalecxtocx
prescriptioncxbycxacxlicensedcxprcxactitioner.cxThecxControlledcxSubstancescxActcxaddressescxonlycxcon
trolledcxsubstancescxandcxtheircxcategocxrization.cxThecxKefauvercxHarriscxDrugcxAmendmentcxensur
escxdrugvefficacycxandcxgreatercxdrugcxsafety.cxDrugcxmanufacturerscxarecxrequiredcxtocxprovevtocxthev
FDAcxthecxeffectivenesscxofcxtheircxproductscxbeforecxmarketingcxthem.
DIF: CognitivecxLevel:cxKnowledge
REF:c x p.cx5cxTablecxl.3cxOBJ:c x 5
NAT:cxNCLEXcxClientcxNeedscxCategory:cxPhysiologicalcxIntegrit
ycxTOP:c x NursingcxProcesscxStep:cxAssessment
CON:c x Safetycx|cxPatientcxEducationcx|cxEvidencecx|cxHealthcxCarecxLaw
7. Whichcxclassificationcxdoescxmeperidinecx(Demerol)cxfallcxunder?
a. I
b. II
c. III
d. IV
ANS:cxB
Meperidinecx(Demerol)cxiscxacxSchedulecxIIcxdrug;cxitcxhascxacxhighcxpotentialcxforcxabusecxandcxmaycxle
adcxtocxsecxverecxpsychologicalcxandcxphysicalcxdependence.cxSchedulecxIcxdrugscxhavecxhighcxpotential
cxforcxabusecxandcxnocxrecognizedcxmedicalcxuse.cxSchedulecxIIIcxdrugscxhavevsomecxpotentialcxforcxa
buse.cxUsecxmaycxleadcxtocxlowcxtocxmoderatecxphysicalcxdependencecxorcxhighcxpsychologicalcxdepen
dence.cxSchedulevIVcxdrugscxhacxvecxlowcxpotentialcxforcxabuse.cxUsecxmaycxleadcxtocxlimitedcxphysi
calcxorcxpsychologicalcxdependence.
DIF:c x c x CognitivecxLevel:cxKnowledge REF:c x p.cx10
OBJ:cx2cxNAT:c x NCLEXcxClientcxNeedscxCategory:cxSafe,cxEffective
cxCarcxecxEnvironment
TOP:c x NursingcxProcesscxStep:cxAssessmentc x c x CON:c x PatientvEducationcx|cxAddictioncx|cxPain
8. WhichcxactioncxwouldcxthecxFDAcxtakecxtovexpeditecxdrugvdevelopmentcxandcxapprovalcxforcxancxoutbr
eakcxocxfcxsmallpox?
a. Listcxsmallpoxcxascxacxhealthcxorphancxdisease.
b. Omitcxthecxpreclinicalcxresearchcxphase.
c. Extendvthecxclinicalcxresearchcxphase.
d. Fastcxtrackcxthecxinvestigationalcxdrug.
ANS:cxD
OncecxthecxInvestigationalcxNewcxDrugcxApplicationcxhascxbeencxapproved,cxthecxdrugcxcancxreceive
cxhighcxestcxprioritycxwithincxthevagency,cxwhichcxiscxcalledcxfastcxtracking.cxAcxsmallpoxcxoutbreakc
xwouldcxbecocxmecxacxprioritycxconcerncxincxthecxworld.cxOrphancxdiseasescxarecxnotcxresearchedcxincxac
xprioritycxmanner.cxPrcxeclinicalcxresearchcxiscxnotcxomitted.cxExtendingvanycxphasecxofcxthecxresearchc
xwouldcxmeancxacxlongercxtimcxecxtocxdevelopcxacxvaccine.cxThecxFDAcxmustcxensurecxthatcxallcxphasescxofcx
thecxpreclinicalcxandcxclinicalcxreseacxrchcxphasevhavecxbeencxcompletedcxincxacxsafecxmanner.
DIF: CognitivecxLevel:cxKnowledge REF:c x p.cx7 OBJ:cx5
